Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
被引:6
|
作者:
Hunter, Sally M.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Hunter, Sally M.
[1
]
Dall, Genevieve V.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Dall, Genevieve V.
[1
]
Doyle, Maria A.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Doyle, Maria A.
[2
]
Lupat, Richard
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Lupat, Richard
[2
]
Li, Jason
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Li, Jason
[2
]
Allan, Prue
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Anat Pathol, East Melbourne, Vic, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Allan, Prue
[3
]
Rowley, Simone M.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Rowley, Simone M.
[1
]
论文数: 引用数:
h-index:
机构:
Bowtell, David
[1
,4
,5
]
Campbell, Ian G.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Univ Melbourne, Dept Pathol, Parkville, Vic, Australia
Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Campbell, Ian G.
[1
,4
,5
]
Gorringe, Kylie L.
论文数: 0引用数: 0
h-index: 0
机构:
Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Univ Melbourne, Dept Pathol, Parkville, Vic, Australia
Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, AustraliaPeter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
Gorringe, Kylie L.
[1
,4
,5
,6
]
机构:
[1] Peter MacCallum Canc Ctr, Canc Genom Program, East Melbourne, Australia
[2] Peter MacCallum Canc Ctr, Bioinformat Core Facil, East Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Anat Pathol, East Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[6] Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia
ObjectiveOvarian fibromas and adenofibromas are rare ovarian tumours. They are benign tumours composed of spindle-like stromal cells (pure fibroma) or a mixture of fibroblast and epithelial components (adenofibroma). We have previously shown that 40% of benign serous ovarian tumours are likely primary fibromas due to the neoplastic alterations being restricted to the stromal compartment of these tumours. We further explore this finding by comparing benign serous tumours to pure fibromas.ResultsPerforming copy number aberration (CNA) analysis on the stromal component of 45 benign serous tumours and 8 pure fibromas, we have again shown that trisomy of chromosome 12 is the most common aberration in ovarian fibromas. CNAs were more frequent in the pure fibromas than the benign serous tumours (88% vs 33%), however pure fibromas more frequently harboured more than one CNA event compared with benign serous tumours. As these extra CNA events observed in the pure fibromas were unique to this subset our data indicates a unique tumour evolution. Gene expression analysis on the two cohorts was unable to show gene expression changes that differed based on tumour subtype. Exome analysis did not reveal any recurrently mutated genes.
机构:
Department of Pathology,the University of Texas M.D.Anderson Cancer CenterDepartment of Pathology,the University of Texas M.D.Anderson Cancer Center